Petra Brockfeld

Petra Brockfeld has a diverse work experience in the healthcare industry. Petra started their career in 2001 as an International Product Manager at Dendron GmbH before moving on to become a Sales/Marketing Manager at Dendron GmbH/Micro Therapeutics Inc. in 2003. Petra then joined ev3 in 2004 as a Marketing Manager for Europe Neurovascular.

In 2008, Petra joined Abiomed as a Director of Marketing & Distributor Sales Europe, where they managed a team of marketing and sales professionals. Petra later became the Marketing Director for Europe at Abiomed.

Petra then moved on to work at ev3 again in 2009 as the Director of Marketing Europe. Petra joined Covidien GmbH in 2010 as the Director of Marketing International and continued in the role when Covidien acquired ev3 later that year. In 2010, they also became a Marketing Director for Medtronic's EMEA region, where they played a key role in the integration of the acquired company Reverse Medical.

From 2016 to 2019, Petra served as the Senior Director of Global Marketing and Clinical Affairs at phenox, a German company specializing in neurovascular disease treatment. Petra later took on the role of VP Global Marketing & Clinical Affairs at phenox, overseeing all marketing and training activities globally. In 2022, phenox was acquired by Wallaby Medical, and Petra supported the integration process in two workstreams.

Most recently, Petra held the position of VP Global Upstream Marketing at phenox, where they continued to lead marketing and clinical affairs initiatives.

Petra Brockfeld received their Ph.D. in Physics from Ruhr University Bochum, where they studied from 1992 to 2000.